MEDIFAST INC (MED) Forecasted to Earn Q3 2017 Earnings of $0.51 Per Share
MEDIFAST INC (NYSE:MED) – Analysts at DA Davidson issued their Q3 2017 earnings per share estimates for shares of MEDIFAST INC in a research report issued on Wednesday. DA Davidson analyst L. Weiser expects that the specialty retailer will earn $0.51 per share for the quarter. DA Davidson has a “Buy” rating on the stock. DA Davidson also issued estimates for MEDIFAST INC’s Q4 2017 earnings at $0.47 EPS, FY2017 earnings at $2.12 EPS, Q1 2018 earnings at $0.58 EPS, Q2 2018 earnings at $0.74 EPS, Q3 2018 earnings at $0.61 EPS, Q4 2018 earnings at $0.57 EPS and FY2018 earnings at $2.50 EPS.
A number of other analysts have also recently issued reports on the company. Sidoti cut MEDIFAST INC from a “buy” rating to a “neutral” rating in a research report on Tuesday, May 2nd. BidaskClub raised MEDIFAST INC from a “sell” rating to a “hold” rating in a research report on Saturday.
TRADEMARK VIOLATION NOTICE: “MEDIFAST INC (MED) Forecasted to Earn Q3 2017 Earnings of $0.51 Per Share” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/08/21/medifast-inc-med-forecasted-to-earn-q3-2017-earnings-of-0-51-per-share.html.
MEDIFAST INC (NYSE:MED) opened at 55.82 on Monday. The stock has a market capitalization of $665.93 million, a PE ratio of 28.05 and a beta of 0.48. MEDIFAST INC has a 52 week low of $35.55 and a 52 week high of $56.41. The stock has a 50 day moving average price of $44.13 and a 200 day moving average price of $43.73.
MEDIFAST INC (NYSE:MED) last announced its quarterly earnings data on Tuesday, August 8th. The specialty retailer reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.53 by $0.10. MEDIFAST INC had a return on equity of 24.25% and a net margin of 8.62%. The firm had revenue of $75.70 million during the quarter, compared to analysts’ expectations of $71.96 million. During the same period last year, the business posted $0.63 earnings per share. The company’s revenue for the quarter was up 6.5% compared to the same quarter last year.
Several hedge funds have recently made changes to their positions in MED. Seizert Capital Partners LLC purchased a new stake in shares of MEDIFAST INC during the first quarter worth about $3,716,000. Marshall Wace North America L.P. increased its stake in MEDIFAST INC by 356.6% in the second quarter. Marshall Wace North America L.P. now owns 103,812 shares of the specialty retailer’s stock valued at $4,256,000 after buying an additional 81,075 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in MEDIFAST INC by 197.0% in the second quarter. Goldman Sachs Group Inc. now owns 89,606 shares of the specialty retailer’s stock valued at $3,716,000 after buying an additional 59,437 shares in the last quarter. LSV Asset Management increased its stake in MEDIFAST INC by 235.2% in the first quarter. LSV Asset Management now owns 73,066 shares of the specialty retailer’s stock valued at $3,241,000 after buying an additional 51,266 shares in the last quarter. Finally, Bank of America Corp DE increased its stake in MEDIFAST INC by 501.5% in the first quarter. Bank of America Corp DE now owns 51,353 shares of the specialty retailer’s stock valued at $2,278,000 after buying an additional 42,815 shares in the last quarter. 92.09% of the stock is owned by hedge funds and other institutional investors.
The company also recently announced a quarterly dividend, which was paid on Wednesday, August 9th. Investors of record on Friday, June 23rd were given a $0.32 dividend. The ex-dividend date was Wednesday, June 21st. This represents a $1.28 dividend on an annualized basis and a dividend yield of 2.29%. MEDIFAST INC’s dividend payout ratio (DPR) is presently 64.32%.
MEDIFAST INC Company Profile
Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.
Receive News & Stock Ratings for MEDIFAST INC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDIFAST INC and related stocks with our FREE daily email newsletter.